Sol-Gel Technologies Ltd.
SLGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684693
In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 7 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Sol-Gel Technologies Ltd. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 10 | 14 | +4 |
| Shares | 558.5K | 716.7K | +158.2K (+28.3%) |
| Value | $16.3M | $30.2M | +$13.9M (+85.5%) |
New holders (5)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Yelin Lapidot Holdings Management Ltd. | 17,753 | $748.1K | 0.15% |
| Citadel Advisors LLC | 6,199 | $264.3K | 0.00% |
| Raymond James Financial Inc | 5,735 | $241.7K | 0.00% |
| UBS Group AG | 1,273 | $53.6K | 0.00% |
| Royal Bank of Canada | 146 | $6.00K | 0.00% |
Sold out (1)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Migdal Insurance & Financial Holdings Ltd. | 122,755 | $3.58M |